List of Rottapharm patents

List of Rottapharm patents

List of Graphcore Limited patents

List of University of Maryland patents

List of JCR Pharmaceuticals patents

List of patents in the Real-time bidding industry

Companies in the Coaching industry

Patents where

Current Assignee

Name

is

Rottapharm

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11590114 Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumours	Patent 11590114 was granted and assigned to Rottapharm on February, 2023 by the United States Patent and Trademark Office.	Rottapharm	Rottapharm		United States Patent and Trademark Office	11590114	February 28, 2023
	‌ US Patent 9493438 4,4-difluoro-piperidine-compounds	Patent 9493438 was granted and assigned to Rottapharm on November, 2016 by the United States Patent and Trademark Office.	Rottapharm	Rottapharm		United States Patent and Trademark Office	9493438	November 15, 2016
	‌ US Patent 9631029 Anti-ADAMTS-5 antibody, derivatives and uses thereof	Patent 9631029 was granted and assigned to Rottapharm on April, 2017 by the United States Patent and Trademark Office.	Rottapharm	Rottapharm		United States Patent and Trademark Office	9631029	April 25, 2017
	‌ US Patent 9365654 Anti-TrkA antibodies, derivatives and uses thereof	Patent 9365654 was granted and assigned to Rottapharm on June, 2016 by the United States Patent and Trademark Office.	Rottapharm	Rottapharm		United States Patent and Trademark Office	9365654	June 14, 2016
	‌ US Patent 9623108 Formulation for oral administration with beneficial effects on the cardiovascular system	Patent 9623108 was granted and assigned to Rottapharm on April, 2017 by the United States Patent and Trademark Office.		Rottapharm		United States Patent and Trademark Office	9623108	April 18, 2017
	‌ US Patent 9498478 Spiro aminic compounds with NK1 antagonist activity	Patent 9498478 was granted and assigned to Rottapharm on November, 2016 by the United States Patent and Trademark Office.	Rottapharm	Rottapharm		United States Patent and Trademark Office	9498478	November 22, 2016
	‌ US Patent 10125121 FYN kinase inhibitors	Patent 10125121 was granted and assigned to Rottapharm on November, 2018 by the United States Patent and Trademark Office.	Rottapharm	Rottapharm		United States Patent and Trademark Office	10125121	November 13, 2018
	‌ US Patent 9062033 Chemical compounds	Patent 9062033 was granted and assigned to Rottapharm on June, 2015 by the United States Patent and Trademark Office.	Rottapharm	Rottapharm		United States Patent and Trademark Office	9062033	June 23, 2015
	‌ US Patent 9174977 2-azabicyclo[4.1.0]heptane derivatives as orexin receptor antagonists for the treatment of certain disorders	Patent 9174977 was granted and assigned to Rottapharm on November, 2015 by the United States Patent and Trademark Office.	Rottapharm	Rottapharm		United States Patent and Trademark Office	9174977	November 3, 2015
	‌ US Patent 8859608 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction	Patent 8859608 was granted and assigned to Rottapharm on October, 2014 by the United States Patent and Trademark Office.		Rottapharm		United States Patent and Trademark Office	8859608	October 14, 2014
	‌ US Patent 9120824 Cyclic amine derivatives as EP	Patent 9120824 was granted and assigned to Rottapharm on September, 2015 by the United States Patent and Trademark Office.		Rottapharm		United States Patent and Trademark Office	9120824	September 1, 2015
	‌ US Patent 9162979 1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors	Patent 9162979 was granted and assigned to Rottapharm on October, 2015 by the United States Patent and Trademark Office.		Rottapharm		United States Patent and Trademark Office	9162979	October 20, 2015
	‌ US Patent 9181279 Cyclic amine derivatives as EP	Patent 9181279 was granted and assigned to Rottapharm on November, 2015 by the United States Patent and Trademark Office.		Rottapharm		United States Patent and Trademark Office	9181279	November 10, 2015
	‌ US Patent 8828987 Pyridine amide derivatives as EP4 receptor antagonists	Patent 8828987 was granted and assigned to Rottapharm on September, 2014 by the United States Patent and Trademark Office.		Rottapharm		United States Patent and Trademark Office	8828987	September 9, 2014

14 results

0 selected

14 results

0 selected